Chris Outram, Chair
Christine was appointed as Chair of The Christie in October 2014.
Christine has had a long career in the NHS with over 20 years' experience at Chief Executive level, including the North Central London Strategic Health Authority and NHS Leeds, as well as a spell as Director General for the Department of Health’s Arm’s Length Body Review in 2004.
With a strong interest in professional education and research, she was appointed managing director of NHS Medical Education England in 2009, an organisation set up to support the Department of Health’s work to develop education and training for doctors, dentists, pharmacists and healthcare scientists. She later combined this role with that of transition director leading on the set up of Health Education England in 2011.
Chris holds an MBA from the London Business School, and a modern languages degree from Heriot Watt University Edinburgh. Prior to joining the NHS, she worked as a conference interpreter and in the Department of Trade and Industry. Her first role in the NHS was as a patient advocate, and she continues to be passionate about working with clinical staff and patients to provide excellent services and outcomes for people.
Chris was awarded an MBE in the Queen’s Birthday honours list in June 2019.
Roger Spencer, Chief Executive
Roger Spencer has been the Chief Executive since December 2013.
Roger has managed significant Christie service developments including creation of a network of oncology (radiotherapy and chemotherapy) centres which have transformed delivery of services for the 3.2m population of Greater Manchester and Cheshire. He led the establishment of The Christie’s innovation partnerships with government, commercial, third sector and academic organisations. These include pathology, specialist diagnostic services, private patients (HCA Healthcare- The Christie Private Care) and an academic investment partnership.
In 2016 he led the Trust to a CQC Outstanding rating, repeated again in 2018. In the same year The Christie opened the UK’s first national proton service
Roger led for Greater Manchester on the National Cancer Vanguard developing and testing new models of care. He is the Chair of Greater Manchester Cancer Alliance GM Cancer and the Greater Manchester Clinical Research Network GM CRN and a member of the Manchester Cancer Research Centre Steering Board MCRC Governance, working with a comprehensive group of stakeholders to improve and develop leading edge cancer services.
He is frequently invited to lecture and publishes articles on the subject of cancer care. He is a member of the National Cancer Board of NHS England and chairs their Early Detection and Screening Task and Finish Group.
In December 2018 he was appointed to the Healthcare UK Advisory Board
Bernie Delahoyde, Interim Chief Operating Officer
Bernie was appointed as interim chief operating officer at The Christie in February 2020. She is the former director of operations and deputy chief operating officer, a post which she held from 2014 to 2020. Before that, she was the general manager of the programme management office.
Bernie is also a director of The Christie Clinic and The Christie Pathology Partnership.
Before coming to The Christie, Bernie worked in managerial roles at Salford Royal Hospitals and Trafford General Hospital. She qualified and worked as a registered nurse before moving into managerial roles.
Professor Chris Harrison, Executive Medical Director (Strategy), and Deputy CEO
Chris was appointed as executive medical director from 1 February 2016 and combined this role with that of National Clinical Director for Cancer at NHS England, a post he held until September 2018. Chris holds an honorary Clinical Professor position at the Manchester Academic Health Sciences Centre and continues to hold an honorary professor position at Imperial College, London.
Chris was the Medical Director and Responsible Officer at Imperial College Healthcare NHS Trust from 2013 until 2016 during which period he was also the vice chairman of the London Clinical Senate. As Medical Director he was responsible for all aspects of the clinical strategy, clinical governance and medical professional leadership for a London teaching hospital with over 1000 doctors. He was also the executive director with responsibility for research and medical education.
Before moving to London Chris was Medical Director at The Christie between 2005 and 2013. During this time he led the work leading to development of the networked radiotherapy satellite facilities in Salford and Oldham and established the long term clinical strategy for the Christie. He established Manchester Cancer an integrated cancer system which has since evolved into the Greater Manchester Cancer programme and designated as part of the national cancer vanguard. Between 2010 and 2012 he was seconded part time to NHS London to lead development of cancer services across the capital, establishing the arrangements for the two London based integrated cancer systems which are also part of the national cancer vanguard.
He had previously held posts as head of the regional cancer team at North West Regional Office, deputy regional director of public health at North West Regional Office, director of the Greater Manchester Health Protection Unit and medical director and director of public health at Greater Manchester Strategic Health Authority. From 1992 he was director of public health for The South Lancashire Health Authority (Ormskirk, Chorley, South Ribble) and in 1996 director of public health and commissioning for North West Lancashire Health Authority (Preston and Blackpool). During this period he was the executive director responsible for overseeing the development of the new radiotherapy service in Preston.
He has been involved in numerous national and international committees relating to cancer care, quality of care and standards of clinical practice. He led the first region wide cancer peer review programme and later chaired the accreditation committee of the Organisation of European Cancer Institutes which oversaw the peer review programme for cancer centres in Europe. He is frequently invited to lecture on cancer care policy in the UK and abroad.
Dr Wendy Makin, Executive Medical Director
Dr Makin initially trained as a clinical oncologist at The Christie. Following this she gained 5 years experience based as a consultant based at St Oswald's Hospice in Newcastle upon Tyne, before returning to Manchester in 1995. She led the development of the multidisciplinary palliative care service at The Christie and helped to establish higher specialist training in palliative medicine in Greater Manchester. Wendy was Deputy Medical Director and Responsible Officer from 2011-16
Wendy led a cross-College working party into the urgent care needs of people with cancer in 2012-13 and chaired the palliative medicine specialty committee at the Royal College of Physicians from 2013-16 and was a member of the Joint Collegiate council for Oncology.
For several years she has been engaged in the development of support and information for cancer survivors and took up the new Manchester Cancer pathway director for Living With and Beyond Cancer (LWBC) in 2014. Wendy has been working with the Macmillan Cancer Improvement Project to improve services across the city of Manchester and leads of the LWBC work streams in the National Cancer Vanguard.
Wendy is a member of the Macmillan consultant advisory group, working closely with the Macmillan GP network and a member of the Macmillan Cancer Support clinical advisory board.
Professor Janelle Yorke, Executive Chief Nurse and Director of Quality
Professor Yorke was appointed as Executive Chief Nurse and Director of Quality in April 2020. She continues to hold the inaugural joint Chair in Cancer Nursing with the University of Manchester and The Christie, commencing May 2015.
In 2016, she founded Christie Patient Centred Research (CPCR) and continues to lead this multi-professional group of Christie researchers and students. During that time she also developed the bespoke Christie Clinical Academic Pathway (CCAP) supporting combined clinical and research pathways for cancer nurses and allied health professionals. She is Deputy Chair of Supportive and Palliative Care research at University of Manchester. She has secured research grants over £6M as a lead investigator and £20M as a co-investigator.
Professor Yorke has particular expertise in the development and utilisation of Patient Reported Outcome - and Experience - Measures (PROMS/PREMS). She is internationally recognised as an expert in PROM work; her work includes symptom specific and quality of life measures that have been translated into more than 30 different languages. She chairs The Christie ePROM group, leading the implementation of electronic PROMs into routine clinical care.
In 1991, Professor Yorke graduated from the University of Western Sydney and began her clinical nursing career as an intensive care nurse; she worked in Sydney, London and Saudi Arabia. Prior to relocating to the UK in 2004 she was Nurse Consultant for heart and lung transplantation at St Vincent’s Hospital, Sydney.
Since moving to the UK she completed her PhD and has held numerous academic and leadership roles at the Royal Brompton and Harefield Foundation Trust, Imperial College London and University of Salford. She is also Conjoint Professor at University of Newcastle, Australia.
Professor Yorke holds numerous leadership roles including Chair of Lung Cancer Nurses UK research group, outgoing Chair for the British Thoracic Society and European Respiratory Society nursing groups, and previous Chair of the American Thoracic Society nursing group. She is dedicated to the clinical-academic development of nurses and allied health professionals to benefit patient care and the wider health care setting.
Joanne Fitzpatrick, Executive Director of Finance and Business Development
Joanne was appointed as Executive Director of Finance and Business Development at The Christie on 1st April 2013 and is the former Deputy Director of Finance and Business Development, a post which she held from 2001 to 2013. Prior to that she was the Assistant Director of Finance at The Christie NHS Foundation Trust from 1992 to 2001. Joanne is also a Director of The Christie Clinic and The Christie Pathology Partnership.
In 2011, Joanne was recognised as being one of the top Deputy Directors of Finance in the NHS through the successful attainment of the HFMA Deputy Director of Finance Award.
She is a qualified accountant and holds an ACMA.
Professor Kieran Walshe, Non-Executive Director
- Professor of Health Policy and Management, Manchester Business School and head of health management group
- Board member of the UK Health Services Research Network
- Member of the REF2014 panel for public health, health services research and primary care
- Expert advisor to the House of Commons Health Select Committee 2011-12 and 2014-15
- Associate director of the NIHR health services and delivery research programme (2012-15)
- Board member and scientific committee chair of the European Health Management Association (2008-2015)
- Director of the Institute of Health Sciences, University of Manchester (2009-2011)
- Member of the Council for Healthcare Regulatory Excellence (2003-2008)
Kathryn Riddle, Non-Executive Director
Kathryn was appointed as an interim non-executive director in May 2014 and as a substantive non-executive director from May 2015. Kathryn is the senior independent Non-Executive Director. She also chairs the Charitable Funds Committee and is a member of the audit committee.
Kathryn is a patron of Weston Park Hospital, Sheffield and a patron of St Luke’s Hospice, Sheffield. A former High Sheriff of South Yorkshire, Kathryn is a Deputy Lieutenant of South Yorkshire. She has been involved in Health Services since 1994 chairing the Community Health Trust in Sheffield, the Strategic Health Authority in Yorkshire and the Humber and from 2011-2013 she chaired NHS North of England.
Kathryn, a former lecturer in law, was the first woman to be appointed a Pro-Chancellor at the University of Sheffield and the first female Chair of Council at the University from 2007-2013. Kathryn remains connected with the University as a member of the alumni board.
Kathryn was Honorary Colonel of the Sheffield Universities Officer Training Corps from 2008-2014. A Magistrate since 1975 she chaired the Family Panel at Sheffield and the South Yorkshire Panel of Guardians ad Litem for 8 years. Kathryn retired from the bench in 2015. Kathryn has had associations with a number of charities including Scope, Victim Support and Birthright.
Neil Large, Non-Executive Director
Neil was appointed as an interim Non-Executive Director at The Christie in July 2014; he also chairs the Trust's Audit Committee. He is currently Chairman of the Liverpool Heart and Chest Hospital NHS Foundation Trust having been appointed in December 2009 and was previously a Non-Executive Director for 2 years at that Trust.
Neil is an accountant by profession and has spent most of his career in the NHS holding board level appointments both Chief Executive/Executive and NED positions for over 25 years. His last Executive appointment prior to retirement was as Director of Finance and ICT of the former Cheshire and Merseyside Strategic Health Authority and he was a member of the National Finance Staff Development Committee.
Neil also supports local charitable/voluntary causes being a Trustee of Tarporley Cottage Hospital (Charitable organisation) and a member of the Chester University Audit and Risk Management Committee.
Professor Jane Maher, Non-Executive Director
Jane was appointed from September 2015. She is the non-executive director safeguarding lead and is a member of the Quality Assurance Committee.
Jane has been Macmillan’s Chief Medical Officer since 1999 and now shares the role as Joint CMO with general practitioner, Dr Rosie Loftus, reflecting the growing need for specialists and generalists to work more effectively together.
She has been an NHS Improvement clinical leader for over ten years and is an Honorary Consultant Clinical Oncologist at Mount Vernon Cancer Centre where she has worked for more than 20 years, during which time she helped develop non-surgical oncology services in five district general hospitals. She is an honorary senior clinical lecturer at University College London and Visiting Professor at the University of Hertfordshire.
Jane chaired the Maher Committee for the Department of Health in 1995, led the UK National Audit of Late Effects Pelvic Radiotherapy for the RCR in 2000 and, most recently, chaired the National Cancer Survivorship Initiative Consequences of Treatment work stream. She co-founded one of the first Cancer Support and Information services in the UK, winning the Nye Bevan award in 1992 and there are now more than 60 units based on this model.
She has written more than 150 published articles and advises on cancer survivorship programmes in Denmark and Canada.
Robert Ainsworth, Non-Executive Director
Robert was appointed on 7th March 2016 and is a member of the Audit Committee. Robert was until recently also a non-executive director of Pennine Care NHS Foundation Trust having been appointed in 2008, and served as deputy chairman and senior independent director from 2011. He is also a director of HF Holidays Ltd.
Prior to taking up the role of non-executive director, Robert held several senior management and director positions in the private sector, most recently in Premier Farnell plc, where he was Finance Director of the Europe & Asia Pacific division. This consisted of over twenty businesses across Europe and Asia with a turnover in excess of £400 million.
He was previously Finance Director and Company Secretary of National Tyres and Autocare Ltd and was Executive Director of Finance of GUS Catalogue Order Ltd. He has also been employed by The Co-operative Bank plc, and Price Waterhouse & Co. He has wide experience of general and financial management and much of his career has been spent in competitive industries with a focus on customer service.
He has a degree from Leeds University and he is a Fellow of the Institute of Chartered Accountants in England and Wales.
Tarun Kapur CBE, National Leader of Education
- Chief Executive Officer & Academy Principal, The Dean Trust
- Executive Principal
- Tarun was appointed as the first National Leader of Education (NLE) in the North West and since 2005 has led on many significant School to School support commissions
- Advisor to the Department for Education
- Member of the Steer Committee, developing the Behaviour and Attendance Strategy
- Headteacher, Ashton on Mersey School
- Secondary Headteacher of the Year 2007
- Chairman of the FA and Premier League facilities panel – the largest sports charity in the country
- Director of the Manchester United Foundation Board and Trafford Community Leisure Trust both dedicated to community provision in sport, education and employability
- Knowsley Place Board – Board member helping develop drive forward re-generation and create a successful and prosperous future for Knowsley
- Awarded CBE in 2008 for services to education.
- In 2015 Tarun was nominated as one of 250 of the most influential people in Greater Manchester
- BSc (Hons)